HMG-CoA Reductase Inhibitor Toxicity

Explore clinical trials studying HMG-CoA Reductase Inhibitor Toxicity. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HMG-CoA Reductase Inhibitor Toxicity trial results

Recruiting

NCT04499859

Conditions: Cardiovascular Diseases, HMG-CoA Reductase Inhibitor Toxicity, Heart Diseases, +9 more
Locations: Bucheon St.Mary Hospital Bucheon-si, Gyeonggido, South Korea

St.Vincent's Hospital Suwon, Gyeonggido, South Korea

Uijeongbu St.Mary's Hospital Uijeongbu-si, Gyeonggido, South Korea

Daejeon St.Mary's Hospital Daejeon, South Korea

Completed

NCT01013103

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations: Hippocration Hospital, Athens University Medical School Athens, Attica, Greece

Active, Not Recruiting

NCT04636138

Conditions: HMG-CoA Reductase Inhibitor Toxicity
Locations: University of Kansas Medical Center Kansas City, Kansas, United States